Fluence and Reunion Neuroscience Inc. Announce Partnership on Phase 2 Clinical Study of RE104 for Postpartum Depression
Study monitors to be trained on Fluence platform NEW YORK, April 15, 2024 /PRNewswire-PRWeb/ -- Fluence, a global leader in education, training, and certification for practitioners of psychedelic medicine, and Reunion Neuroscience Inc., a venture backed clinical-stage biopharmaceutical...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: TRI LIC Source Type: news
More News: Brain | Depression | Education | Neurology | Partnerships | Pharmaceuticals | Postnatal Depression | Study | Training | Universities & Medical Training